Danaher ROE 2010-2023 | DHR
Current and historical return on equity (ROE) values for Danaher (DHR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Danaher ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$4.74B |
$53.49B |
9.07% |
| 2023-09-30 |
$5.87B |
$52.42B |
11.42% |
| 2023-06-30 |
$6.30B |
$51.72B |
12.57% |
| 2023-03-31 |
$6.85B |
$51.49B |
14.03% |
| 2022-12-31 |
$7.10B |
$50.09B |
14.95% |
| 2022-09-30 |
$6.64B |
$46.99B |
14.35% |
| 2022-06-30 |
$6.21B |
$46.60B |
13.67% |
| 2022-03-31 |
$6.29B |
$46.36B |
14.16% |
| 2021-12-31 |
$6.27B |
$45.18B |
14.59% |
| 2021-09-30 |
$5.72B |
$43.46B |
13.75% |
| 2021-06-30 |
$5.45B |
$42.77B |
13.54% |
| 2021-03-31 |
$4.60B |
$40.43B |
11.90% |
| 2020-12-31 |
$3.51B |
$39.78B |
9.68% |
| 2020-09-30 |
$3.57B |
$37.97B |
10.52% |
| 2020-06-30 |
$3.37B |
$36.27B |
10.31% |
| 2020-03-31 |
$3.19B |
$31.07B |
10.06% |
| 2019-12-31 |
$2.94B |
$30.28B |
9.24% |
| 2019-09-30 |
$2.43B |
$33.20B |
7.77% |
| 2019-06-30 |
$2.45B |
$32.21B |
8.18% |
| 2019-03-31 |
$2.41B |
$31.57B |
8.41% |
| 2018-12-31 |
$2.65B |
$28.23B |
9.61% |
| 2018-09-30 |
$2.76B |
$27.69B |
10.18% |
| 2018-06-30 |
$2.67B |
$27.22B |
10.06% |
| 2018-03-31 |
$2.55B |
$27.20B |
9.86% |
| 2017-12-31 |
$2.49B |
$26.37B |
9.95% |
| 2017-09-30 |
$2.38B |
$25.38B |
9.84% |
| 2017-06-30 |
$2.20B |
$24.60B |
9.30% |
| 2017-03-31 |
$2.30B |
$23.79B |
9.67% |
| 2016-12-31 |
$2.55B |
$23.08B |
10.64% |
| 2016-09-30 |
$2.50B |
$23.26B |
10.32% |
| 2016-06-30 |
$3.51B |
$25.12B |
14.51% |
| 2016-03-31 |
$3.55B |
$24.58B |
14.82% |
| 2015-12-31 |
$3.36B |
$23.76B |
14.21% |
| 2015-09-30 |
$3.33B |
$23.18B |
14.14% |
| 2015-06-30 |
$2.61B |
$24.17B |
11.01% |
| 2015-03-31 |
$2.59B |
$23.39B |
10.97% |
| 2014-12-31 |
$2.60B |
$23.45B |
11.05% |
| 2014-09-30 |
$2.73B |
$23.81B |
11.71% |
| 2014-06-30 |
$2.64B |
$23.79B |
11.66% |
| 2014-03-31 |
$2.58B |
$23.03B |
11.85% |
| 2013-12-31 |
$2.70B |
$22.45B |
12.84% |
| 2013-09-30 |
$2.54B |
$21.37B |
12.59% |
| 2013-06-30 |
$2.49B |
$20.37B |
12.73% |
| 2013-03-31 |
$2.47B |
$19.75B |
12.98% |
| 2012-12-31 |
$2.39B |
$19.08B |
12.88% |
| 2012-09-30 |
$2.33B |
$18.95B |
12.93% |
| 2012-06-30 |
$2.31B |
$18.37B |
13.22% |
| 2012-03-31 |
$2.36B |
$17.89B |
13.86% |
| 2011-12-31 |
$2.17B |
$16.97B |
13.40% |
| 2011-09-30 |
$2.08B |
$16.56B |
13.47% |
| 2011-06-30 |
$2.20B |
$16.56B |
15.10% |
| 2011-03-31 |
$1.92B |
$14.72B |
14.30% |
| 2010-12-31 |
$1.79B |
$13.77B |
14.09% |
| 2010-09-30 |
$1.59B |
$13.17B |
13.02% |
| 2010-06-30 |
$1.29B |
$12.06B |
11.04% |
| 2010-03-31 |
$1.21B |
$11.85B |
10.72% |
| 2009-12-31 |
$1.15B |
$11.63B |
10.61% |
| Sector |
Industry |
Market Cap |
Revenue |
| Multi-Sector Conglomerates |
Diversified Operations |
$174.406B |
$23.890B |
|
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
|
